Human and mouse leukocytes: different clockwork. by Méndez-Ferrer, Simón




1Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Hematology, 
University of Cambridge, Cambridge CB2 0PT, United Kingdom 
2National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge CB2 0PT, 
United Kingdom 
In this issue of Blood, Zhao et al. use a humanized mouse model to investigate the mechanisms driving daily 
oscillations in circulating human and murine leukocytes. In the same mice, they find human and murine 
circulating leukocytes displaying inverted oscillations, reproducing the trafficking pattern previously 
observed in both species. A novel network regulating circadian leukocyte trafficking is proposed. It involves 
interspecies differences of stress-kinase regulation of reactive oxygen species (ROS), hypoxia-inducible 
factor-1-alpha (HIF-1α) and clock gene-dependent regulation of the CXCL12 receptor CXCR4. This study 
underscores the crosstalk of the genetic clock with metabolism and ROS in the regulation of leukocyte 
migration and reveals new mechanistic players. 
Circadian rhythms allow for the organism’s adjustment to basic day/night changes, such as activity/sleep or 
feeding cycles. These are governed at the organismal level by the pacemaker in the brain, the 
suprachiasmatic nucleus, which receives light input through the retinohypothalamic tract and synchronizes 
peripheral organs via the autonomic nervous system and the hypothalamic-pituitary-adrenal axis on a daily 
basis. At the cellular level, peripheral oscillators exist in many cell types and regulate metabolism, 
proliferation and function. Different clocks interact with each other to ensure robust responses. Core clock 
genes, such as BMAL1/ARNTL1, regulate the transcription of multiple genes, including other clock genes 
that drive transcription-translation loops over 24h (reviewed in
1,2
). 
Oscillations previously found both in the number and the activity of hematopoietic progenitors and 
leukocytes might have important implications for regeneration and response to infections
3-5
. For instance, 
oscillations of Bmal1 expression in inflammatory monocytes regulate chemokine genes and immune 
response
6
. Inverted oscillations in circulating leukocytes have been previously reported in (nocturnal) mice 
and (diurnal) humans
3-5
. In both species leukocytes are preferentially released from the bone marrow into 
circulation during the resting period. However, the mechanisms explaining interspecies differences in 
leukocyte trafficking have remained elusive. 
In this issue of Blood, Zhao et al. create hematopoietic chimeric mice to study the trafficking of human and 
murine leukocytes
7
. The model consists of neonatal NOD-SCID IL-2Rγ-deficient (NSG) mice sublethally 
irradiated and intrahepatically transplanted with CD34+ human fetal liver cells. 8-12 week-old mice carrying 
30-50% human CD45+ cells are then selected for circadian studies. 
Strikingly, the same chimeric mice show inverted trafficking patterns for human and murine leukocytes, 
reproducing the interspecies differences. Previous studies in mice and humans
3,4
 have shown oscillations of 
the CXCL12-CXCR4 signalling pathway, a key regulator of leukocyte migration. In C57BL/6 mice, previous 
studies have shown oscillations in bone marrow Cxcl12 expression
3,8
. Zhao et al. do not find obvious Cxcl12 
mRNA oscillations in NSG mice. However, since the number of experimental mice studied was lower, the 
sampling less frequent and performed at other time points, it remains unclear whether there are 
differences due to the strain/immunodeficiency and/or the transplant setting, or not. A similar 
consideration applies to BMAL1 mRNA expression, which does not seem to oscillate in mouse or human 
leukocytes in the chimeric mice
7
, but has been previously shown to oscillate in leukocyte subsets
6
. 
Regardless of this, the sharp difference of mouse/human leukocyte trafficking in the same environment 
argues for key cell-autonomous mechanisms. Consistent with previous studies
4,8
, they find oscillations in 
CXCR4 expression in antiphase with circulating leukocytes. Blockade of Cxcl12 (which is murine-derived in 
the humanized model) blunts oscillations of both murine and human leukocytes. Blockade of the human 
receptor has similar consequences on the human leukocytes, pointing towards a major role of CXCR4. To 
understand how the murine and human receptors are differentially regulated during circadian cycles, the 
authors profile clock gene expression in leukocytes. Intriguingly, in the humanized model the peripheral 
oscillator appears to be present in mouse leukocytes, but not in human leukocytes. This interesting 
difference points towards species-specific regulation of CXCR4 (and possibly other adhesion receptors) in 
relation to the genetic clock, leaving a fertile area for future studies. 
The authors find that CXCR4 oscillations are abolished in BMAL1-deficient leukocytes, consistent with 
previous findings in mice
4
. Therefore, they hypothesize that a clock network-independent BMAL1 function 
regulates CXCR4. Since HIF-1α expression follows circadian oscillations, regulates CXCR4 and binds BMAL1, 
the authors measure HIF-1α expression and find direct correlations with CXCR4 expression. Since HIF-1α is 
regulated by ROS, they measure ROS levels in human and murine leukocytes and find inverted expression 
patterns during circadian cycles. Treatment with the ROS inhibitor N-acetylcysteine abrogated oscillations 
in HIF-1α, CXCR4 and circulating leukocytes. They then hypothesize that the p38MAPK/MK2 pathway might 
generate opposite ROS levels in murine and human leukocytes. Indeed, the authors show different p38 
phosphorylation levels at distinct circadian time points and elegantly demonstrate that MK2 inhibition 
abolishes circadian oscillations of ROS and the downstream pathways. Notably, MK2 inhibition increases 
ROS in murine leukocytes, whereas it has the opposite effect on the human cells, pointing towards a key 
pathway responsible for the interspecies difference. 
Finally, the authors examine the possible connection of this pathway with the central pacemaker using a 
jet-lag experimental setting. Shifting the light cycles does not only abrogate oscillations of leukocytes, but 
also of p38/MK2 phosphorylation, suggesting that the suprachiasmatic nucleus might be able to regulate 
stress kinases in leukocytes (Figure 1). 
In summary, the detailed study by Zhao et al. expands previous findings on the regulation of the CXLC12-
CXCR4 axis by the genetic clock
3-5
 to interactions with stress kinases and ROS. Other studies have found 
clock gene-independent ROS-related mechanisms that maintain circadian cycles. For instance, ROS-
regulating enzymes, such as peroxiredoxins, are ancient clocks that have been conserved throughout 
evolution
9
. In Arabidopsis, the redox rhythm interacts with the genetic clock to adjust the plant’s response 
to environmental stimuli and pathogens
10
. Studies along these lines will help determine the fine crosstalk 
between metabolic and genetic clocks. This knowledge will likely impact on the successfulness of 
“chronotherapy” approaches. 
Figure 1. Model proposed in the study by Zhao et al. Physiological activation of p38MAPK/MK2 during 
circadian cycles causes differential ROS levels, HIF1α-BMAL1-dependent CXCR4 regulation, explaining 
opposite trafficking patterns of mouse and human leukocytes in chimeric immunodeficient mice. WBC, 
white blood cell. NSG, NOD-SCID IL-2Rγ-deficient mouse. P, phosphorylation. 
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